• Presentations & Publications
• Executive Committee
• Mission & Objectives
• ESGICH bylaws
• ESGICH membership application

Download the latest Annual Report.

The ESGICH Executive Committee elections have concluded and the following members have been elected for the term of 2021-2023:

• Jose Maria Aguado Garcia, Spain (Science Officer)
• Monica Slavin, Australia (Secretary)
• Paolo Grossi, Italy (Chair)
• Carlos Cervera, Canada (Education Officer)
• Christian Van Delden, Switzerland (Treasurer)

The new Executive Committee will take office during the ESGICH meeting at ECCMID this year.

We thank all previous Executive Committee members for their excellent work over the last years and are looking forward to continuing this work.

You can find the full election report here

The Annual Report showcasing the achievements of the previous year is now available to view. 2020 was a challenging year due to COVID-19, but check out the report to see what the Study Group was able to accomplish or plan for the future.

 

Safety of Targeted and Biological Therapies: an Infectious Diseases Perspective

Organised by ESGICH

Madrid, Spain - 12-13 March 2021

Throughout this educational course, the attendees willlearn how to manage and prevent the infectious complicationsassociated with the use of new targeted and biologicaltherapies, with particular focus on the clinical implementationof risk-minimization strategies. The programme will consist of a 2-day conference with formal lectures illustrated with clinical cases and meet-the-expert sessions.

See the course Flyer and Programme here

Register for the course here

Infectious Complications in Haematology Patients, including Stem Cell Transplant Recipients

Co-organised by ESGICH, ESCMID and the International Society Immunocompromised Host (ICHS)

Genoa, Italy, 20 – 21 June 2019

Diagnosis and management of infections in haematology is a difficult exercise. In addition to the old predisposing conditions (neutropenia and mucositis), the increasing use of targeted therapies is posing new challenges. Moreover, colonization or past infection with multidrug resistant (MDR) organisms is one of the factors to take into consideration when deciding whether or not haematological interventions are safe and feasible, since subsequent infections can be fatal. Pathogens considered rare in certain settings enter now the differential diagnosis because of the new therapeutic approaches and patients’ mobility. Additionally, antimicrobial stewardship in this population is particularly important to optimize the treatment outcomes, prevent the spread of MDR bacteria and preserve antibiotic activity for future infections. In all these situations, close collaboration between treating haematologists and infectious diseases and microbiology specialists is fundamental. This course offers a comprehensive update on all these issues provided by a multidisciplinary team.

Programme

Course material in the ESCMID eLibrary

April 13, 2019

ESGICH has a new executive committee composed of:

• Chairperson: Prof. Paolo Antonio Grossi, Italy
• Secretary: Dr Monica Slavin, Australia
• Treasurer: Prof. Christian Van Delden, Switzerland
• Science Officer: Prof. Jose Maria Aguado Garcia, Spain
• Education Officer: Dr Carlos Cervera, Canada

Nicolas Mueller and Julien Coussement as members of the election committee invited the membership to nominate candidates and vote. The results of the elections are the following:

• Number of members with voting right: 140
• Number of voters: 53 (37.9%)

Candidates:

• José M. Aguado, Spain         34, elected
• Monica Slavin Peter, Australia        26, elected
• Paolo Grossi, Italy        21, elected
• Christian Van Delden, Switzerland        18, elected
• Carlos Cervera, Canada 30.19%        16, elected
• Edson Abdala, Brazil 20.75%        11, non-elected
• Yasemin Cag, Turkey 16.98%        9, non-elected
• Bernd Salzberger, Germany        7, non-elected
• No preference        1

The new executive committee is elected for two years.